A groundbreaking shift in the country's drug policy has occurred, as the regulators allow the availability of psilocybin fungi for therapeutic applications. Before this, these substances were strictly restricted, but a mounting body of studies suggests they may offer relief for emotional conditions like depression. This change represents a substant